• OPEN AN ACCOUNT
Indian Indices
Sensex
73,758.40 -94.50
( -0.13%)
Global Indices
Nasdaq
52,511.77 524.74
(1.01%)
Dow Jones
7,731.20 19.47
(0.25%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,731.75 -32.94
(-0.31%)
Forex
USD-INR
94.90 0.12
(0.13%)
EUR-INR
106.44 -0.03
(-0.02%)
GBP-INR
126.38 0.12
(0.10%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
48.09
1160.13
EPS(TTM)
Face Value()
Div & Yield %
20.47
10
0.05
 

Sobha gains after total sales value climbs 76% YoY in Q1 FY27
Jul 06,2026
Sales area climbed 61.72% to 23,35,486 square feet (sq.ft) in Q1 FY27, compared with 14,44,117 sq.ft in Q1 FY26. The average price stood at Rs 15,655 per sq.ft in Q1 FY27, up 8.75% YoY.

Bangalore recorded its strongest-ever quarterly sales, registering sales value of Rs 2,067 crore, accounting for 56.5% of the company’s total sales. The NCR region recorded total sales value of Rs 1,384 crore, contributed 37.9% of total sales. Kerala region contributed Rs 134 crore (3.7%), while other cities collectively contributed Rs 71 crore, representing 1.9% of total sales value.

Sobha is the real estate brand in the country that offers international-quality homes and commercial and contractual projects delivered on time through its backward integration model.

The company reported a 124.8% surge in consolidated net profit to Rs 91.84 crore on a 60.2% rise in revenue from operations to Rs 1,987.84 crore in Q4 FY26 over Q4 FY25.